terraplasma medical
Jens Kirsch has extensive experience in the medical technology sector, currently serving as Managing Director of terraplasma medical GmbH since April 2016, where the focus is on cold atmospheric plasma technology for treating medical indications such as chronic wounds. Prior to this role, Jens held various positions, including Chief Executive Officer at Dynamify GmbH until December 2022, and Senior Sales Marketing Consultant at DITABIS AG from August 2018 to March 2021. Additional roles include Business Development Manager at terraplasma emission control GmbH, Project Manager at SOLIN AG, and Consultant at Altran GmbH & Co. KG, specializing in medical imaging software development. Early career experiences include internships focused on medical imaging algorithms and software development at TomTec Imaging Systems and Hansen Medical. Jens holds a Master's degree in Mathematics and Computer Science along with a Dipl.-Tech.-Math in Applied Mathematics and Medical Device Technology, both from the Technical University of Munich.
This person is not in any teams
This person is not in any offices
terraplasma medical
Founded in March 2016, terraplasma medical's vision is to sell and distribute cold atmospheric plasma devices for the treatment of chronic and acute wounds and skin diseases for the professional use. The 'plasma care' device is addressing the wound healing of chronic and acute wounds by effectively using cold atmospheric plasma to inactivate the bacteria located in the wound. The 'plasma care' device offers the following benefits to its customers: - Effective: By using cold plasma, bacteria on the wound surface is inactivated in a few seconds. This is also true for multi-resistant bacteria. The use of antiseptics and antibiotics is reduced at the same time. - Fast: The daily plasma treatment only takes approximately 60s. - Painless: The treatment itself is painless and is therefore well-tolerated by patients. - No side effects: There are no indications of allergic reactions. - Mobile & simple: The 'plasma care' device is battery-operated and simple to use. - Clinical research: plasma medicine in general is widely accepted today. Nevertheless terraplasma medical has conducted extensive pre-clinical studies for safety and efficacy. Further terraplasma medical has started a multicenter clinical trial and observational studies. This platform is used to inform and get in contact with people interested in wound care and potential clients, like clinics, wound centers, general practitioners, medical specialists, as well as home care services and nursery homes.